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Background: The majority of non-syndromic colorectal cancers (CRCs) can be described as a complex disease. A
two-stage case–control study on CRC susceptibility was conducted to assess the influence of the ancestral alleles in
the polymorphisms previously associated with nutrition-related complex diseases.
Methods: In stage I, 28 single nucleotide polymorphisms (SNPs) were genotyped in a hospital-based Czech
population (1025 CRC cases, 787 controls) using an allele-specific PCR-based genotyping system (KASParW). In stage
II, replication was carried out for the five SNPs with the lowest p values. The replication set consisted of 1798 CRC
cases and 1810 controls from a population-based German study (DACHS). Odds ratios (ORs) and 95% confidence
intervals (CIs) for associations between genotypes and CRC risk were estimated using logistic regression. To identify
signatures of selection, Fay-Wu’s H and Integrated Haplotype Score (iHS) were estimated.
Results: In the Czech population, carriers of the ancestral alleles of AGT rs699 and CYP3A7 rs10211 showed an
increased risk of CRC (OR 1.26 and 1.38, respectively; two-sided p≤0.05), whereas carriers of the ancestral allele of
ENPP1 rs1044498 had a decreased risk (OR 0.79; p≤0.05). For rs1044498, the strongest association was detected in
the Czech male subpopulation (OR 0.61; p=0.0015). The associations were not replicated in the German population.
Signatures of selection were found for all three analyzed genes.
Conclusions: Our study showed evidence of association for the ancestral alleles of polymorphisms in AGT and
CYP3A7 and for the derived allele of a polymorphism in ENPP1 with an increased risk of CRC in Czechs, but not in
Germans. The ancestral alleles of these SNPs have previously been associated with nutrition-related diseases
hypertension (AGT and CYP3A7) and insulin resistance (ENPP1). Future studies may shed light on the complex
genetic and environmental interactions between different types of nutrition-related diseases.
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Colorectal cancer (CRC; OMIM ID: 114500) is among the
most common cancers in industrialized countries and one
of the leading causes of cancer-related mortality [1]. The
incidence rates vary among different groups and popula-
tions depending on sex, age and country, with higher rates
among males than females and increasing with age [2].
The differences in the incidence rates across the globe are* Correspondence: s.huhn@dkfz.de
1Department of Molecular Genetic Epidemiology, German Cancer Research
Center DKFZ, Heidelberg 69120, Germany
Full list of author information is available at the end of the article
© 2012 Huhn et al.; licensee BioMed Central L
Commons Attribution License (http://creativec
reproduction in any medium, provided the ormainly attributed to differences in diet and other environ-
mental factors.
In both sporadic and familial CRC, genes and environ-
ment together contribute to the risk of CRC. The major-
ity of non-syndromic CRCs can be characterized as a
complex disease [3]. The major factors that modify CRC
risk are obesity, diabetes, red meat consumption, phys-
ical inactivity, alcohol consumption, chronic inflamma-
tion, and cigarette smoking [4-6]. Additionally, the
intake of vitamin D, calcium, fruit and vegetables may
potentially influence the risk of CRC [5]. Gene-
environment interactions also underlie other complextd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Workflow for the selection of candidate SNPs for the
ancestral susceptibility project.
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betes mellitus type II (T2D; OMIM ID: 125853).
A specific feature of CRC and other complex diseases
is that they are mainly diseases of humans living in
industrialized societies, in environments with almost un-
limited food supply and low energy expenditure [5,7].
Nutrition is one of the most important environmental
traits influencing the fitness of an individual. In the past
centuries, the genetic constitution of an individual was
supposed to optimize food utilization in order to protect
against malnutrition. In modern societies, the ancestral
genetic constitution might not be beneficial anymore,
because it does not protect against the relatively new
condition of overnutrition. Therefore, variants that pro-
tect against overnutrition and related health issues are
supposed to be rare [7]. Nevertheless, genetic variants
that promote a carbohydrate-based nutrition as well as
genetic variants that show ancestral susceptibility to a
nutrition-related disease have already been described
(inter alia [8-10]). Signatures of such processes can be
detected in the human genome using genome-wide
approaches that evaluate differences in the world-wide
allele frequencies and haplotype distribution (inter alia
[11-15]).
Based on the interplay between genetic and environ-
mental risk factors in nutrition-related complex diseases
we posed the following hypothesis: “Polymorphisms with
ancestral alleles associating with a nutrition-related dis-
ease and showing signatures of recent selection may be
associated with CRC risk.” We outline here the methods
used for selecting such candidate genes and show the
results when the selected variants were tested for CRC
risk in two large case–control studies.
Methods
Candidate SNP selection for the case–control study
The study focused on SNPs, for which ancestral alleles
have previously been associated with nutrition-related
complex diseases other than CRC, such as obesity, T2D
and metabolic syndrome. Information about such SNPs
was collected from 30 published reports by browsing the
PubMed database (http://www.ncbi.nlm.nih.gov/sites/
entrez?db=pubmed) [16] for the keywords “diabetes”,
“obesity”, “metabolic syndrome” (OMIM ID: 605552)
and “hypertension” (OMIM ID: 145500) up to 06/2009.
Most of the articles were based on genome-wide associ-
ation studies or were meta-analyses. A complete list of
the publications can be found at the reference list of the
Additional file1.
From these 30 reports, associations with the risk of
the diseases and with the related quantitative traits were
retrieved. The quantitative traits for diabetes were fast-
ing glucose level and insulin resistance. For obesity, the
traits were body mass index (BMI) and waist to hipratio. The quantitative traits for hypertension and the
metabolic syndrome were high-density lipoprotein
(HDL) level, low-density lipoprotein (LDL) level, trigly-
cerides level, salt sensitivity, blood pressure and insulin
resistance. A complete list of the reported associations
can be found in the Additional file 1.
The candidate SNP selection for the association study
took place in three major phases (Figure 1):
(1) “Selection of Candidate SNPs”: All published SNPs
were evaluated for the nature of the risk allele – either
ancestral (A) or derived (D) - and the allele frequency
differences between African, European and Asian popu-
lations (YRI: Sub-Saharan African population, Yoruba in
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dents with Northern and Western European ancestry
from the CEPH collection; HCB: East Asian population,
Han Chinese in Beijing, China; JPT: East Asian popula-
tion, Japanese in Tokyo, Japan). An allele was considered
a “risk allele” when it was associated with a significantly
increased risk of a key-disease (OR>1; statistical signifi-
cance based on the criteria of the original publication),
or when it was associated with a significant increase of
quantitative values in the original publication. The na-
ture of the risk allele was determined by using the NCBI
database (http://www.ncbi.nlm.nih.gov) [16].
The reported ancestral susceptibility SNPs that showed
an absolute allele frequency difference of >45% between
the African and any non-African population were
chosen for further investigation. The threshold value of
45% was set to detect variants with a “major-to-minor”
allele change between populations, thus indicating a pos-
sible influence of selective pressure. A second, lower
threshold (25%) was set for the difference between the
YRI and the CEU population to acknowledge the more
recent separation of the European than the East Asian
population from the African population.
(2) “Candidate Gene Definition”: The SNPs that passed
the first selection criteria were evaluated for their loca-
tion in the genome, possible functional effects, linkage
disequilibrium (LD) with other polymorphisms within
the gene region and the number of candidate SNPs in
the gene region.
(3) “Tagging SNP Approach”: In addition to the evalu-
ation of the reported ancestral susceptibility SNPs, a tag-
ging SNP approach was carried out for each candidate
gene or gene region using the genotyping data of the
CEU population and HaploView© software [17]. Next to
a minor allele frequency (MAF) of ≥5%, a tagging SNP
had to feature the following parameters:
– be or capture a phase 1 SNP and/or
– be or capture a functional polymorphism and/or
– capture a maximal number of SNPs within a
candidate gene or gene region with >25% allele
frequency difference between the YRI and the CEU
population
In the majority of cases, the reported ancestral suscep-
tibility SNP itself was genotyped. When that was not
possible (e.g. because the assay design failed due to the
structure of the surrounding sequence) another SNP
that was in LD with the reported SNP (r2>0.9) was
selected for genotyping in order to indirectly gain infor-
mation about the reported ancestral susceptibility SNP.
For large, diverse genes/gene clusters, additional tagging
SNPs were selected in order to gain more knowledge
about the genes. These tagging SNPs should also fulfilthe criterion of >25% allele frequency difference between
the YRI and CEU population (Table 1).
Allele frequencies were obtained from the NCBI data-
base for the submitter population IDs: HapMap -CEU,
-YRI, -HCB and -JPT (NCBI dbSNP Build 130; http://
www.ncbi.nlm.nih.gov) [16]. LD/r2 was obtained from
HapMap using the HapMap3 - and HapMart Genome
Browser (Release #2, Phase 3; http://hapmap.ncbi.nlm.
nih.gov) [28,29] and HaploView© software (Version 3,
Release 2, Analyse Panel CEU) [17] with the implemen-
ted Tagger tagSNP selection algorithm [30]. The data
about possible functionality originate from the NCBI




First, a hospital-based study population from the Czech
Republic was analyzed. Between 09/2004 and 05/2009,
1025 CRC cases were recruited by nine oncological
departments in the Czech Republic [32]. The sampled
patients showed positive colonoscopic results for malig-
nancy, histologically confirmed as colon or rectal carcin-
omas. The patients who met the Amsterdam criteria I or
II for hereditary nonpolyposis colorectal cancer (OMIM
ID: 120435) were excluded from the study. During the
same time period, 787 healthy controls were recruited
by five gastroenterological departments of the Czech Re-
public [32]. They were individuals undergoing colonos-
copy for various gastrointestinal complaints, such as
macroscopic bleeding, positive faecal occult blood test
or abdominal pain of unknown origin. Only individuals
showing negative colonoscopic results for malignancies,
colorectal adenomas, benign polyps or inflammatory
bowel disease were eligible for the study. Beside general
information about sex and age, information about BMI
(OMIM ID: 606641) and diabetes status was available
for most of the individuals (Table 2).
The SNPs that showed nominally significant associa-
tions in the Czech population were additionally analysed
in a German population-based case–control study. The
DACHS (Darmkrebs: Chancen der Verhütung durch
Screening) study contributed 1798 cases and 1810
matched controls recruited from 01/2003 to 12/2007 in
South-West Germany [33,34]. The patients included in
the study had a first diagnosis of invasive CRC. As con-
trols, individuals were randomly selected from lists of
residents provided by the population registries. In the
detailed standardized questionnaires, information about
BMI at least five years before sampling and diabetes sta-
tus was available in addition to general information
about sex and age [34]. Table 2 outlines the characteris-
tics of the Czech and the DACHS population relevant
for the study.


























rs699 R/G Chr1: 228.912.667 C/T Hypertension,
Preeclampsia
52,5% 52,5% missense [9,18]
rs4762 R Chr1: 228.912.850 C/T Hypertension 3,3% 3,3% missense
rs5051
(r2 0.948 to rs699)





rs4846914 R/G Chr1: 228.362.564 G/A HDL 58,0% 58,0% intron [19,20]
rs611229 G Chr1: 228.390.690 G/T tagging SNP 39,4% 39,4% intron -
rs2144300
(r2 0.933 to rs4846914)
R Chr1: 228.361.789 C/T HDL, Triglycerides 57,0% 57,0% intron [20]
IFIH1
Interferon induced with
helicase C domain 1




Solute carrier family 2, facilitated
glucose transporter member 2
rs5400 R/G. Chr3: 172.215.244 T/C T2D 48,1% 35,0% missense /
damaging
[9]
rs6785233 G Chr3: 172.239.679 G/T tagging SNP 50,8% 38,3% - -
rs8192675 G Chr3: 172.207.577 G/A tagging SNP 76,7% 50,0% - -
IGF2BP2
Insulin-like growth factor 2
mRNA binding
rs1470579 R/G Chr3: 187.012.024 C/A T2D 60,0% 56,8% intron [22]
ENPP1
Ectonucleotide pyrophosphatase




94,4% 87,3% missense /
benign
[9,23]
rs9493119 G Chr6: 132.253.111 G/A tagging SNP 30,0% 20,8% - -
CYP3A_ Locus
Cytochrom P450
rs776746 R/G. Chr7: 99.108.725 A/G Hypertension;
Salt sensitivity
79,2% 79,2% CYP3A5_ intron [9,18]
rs10211 G Chr7: 99.140.930 G/A tagging SNP 67,0% 67,0% 30UTR_CYP3A7 -
rs667660 G Chr7: 99.257.162 C/A tagging SNP 74,3% 74,3% upstream CYP3a3 -
MTMR9
Myotubularin related protein 9
rs10091637 G Chr8: 11.181.724 C/T tagging SNP 36,9% 29,2% intron -
rs11250127 G Chr8: 11.207.619 G/A tagging SNP 66,4% 26,5% intron -
rs2293855
(r2 1.00 to rs11250127)
R Chr8: 11.215.070 G/A Obesity 64,2% 25,2% intron [24]
ABCA1
ATP-binding cassette transporter
rs4149268 R/G. Chr9: 106.687.291 T/C HDL 51,0% 46,0% intron [20]
rs4149274 R Chr9: 106.679.485 A/G HDL 4,0% 2,0% intron [20]
rs1883025 R Chr9: 106.704.372 T/C HDL 13,5% 10,0% intron [19]
GAD2
Glutamate decarboxylase 2
rs2236418 R/G. Chr10: 26.545.752 G/A Obesity 74,9% 74,9% 50UTR [9]




















Table 1 Information about genes and SNPs selected for the SNP association study (Continued)
rs6482538 G Chr10: 26.549.870 G/A tagging SNP 63,6% 63,6% intron -
rs7076544 G Chr10: 26.597.731 G/A tagging SNP 68,0% 68,0% intron -
rs8190748 G Chr10: 26.609.761 G/A tagging SNP 60,20% 60,20% intron -
Chr 12q13 ERBB3
Avian erythroplastic leukemia
viral oncogen homolog 3






rs7298565 G Chr12: 108.421.917 A/G tagging SNP 57,7% 24,1% missense -
rs2338104
(r2 0.98 to rs7298565)





Cytochrom P450 / Gliomedin
rs2446405 R/G Chr15: 49.434.335 A/T Insulin
Resistance
43,0% 43,0% GLDN intron [25]
rs12592797 G Chr15: 49.426.928 A/C tagging SNP 52,5% 52,5% GLDN intron -
rs2445761 G Chr15: 49.402.908 C/T tagging SNP 40,9% 40,9% CYP19A1 intron -
BBS4
Bardet-Biedl syndrome-4
rs7178130 R/G Chr15: 70.765.505 G/A Bardet-Biedl
Syndrome;
Obesity




frame 8 / Niemann-Pick
disease, type C1





(r2 0.84 to rs891386)
R Chr18: 19.394.680 A/G BMI 46,7% 46,7% missense
R reported SNP; G genotyped SNP; “R/G” reported and genotyped SNP. Max. maximal; BMI body mass index, T2D type 2 diabetes, LDL low-density lipoprotein, HDL high-density lipoprotein, Ref. reference a genotyped
SNPs are indicated in bold; b pair-wise linkage disequilibrium between the SNPs, if reported SNP was not genotyped directly; c reported risk allele is indicated in bold-underlined; d Next to the keywords that were used




















Table 2 Characteristics of the Czech and the DACHS study population, at the time of diagnosis for cases and at the
time of sampling for controls
Characteristics Czech Cases Czech Controls p value DACHS Cases DACHS Controls p value
total 1025 787 1798 1810
male [n (%)] 594 [58%] 453 [58%] 0.35c 1052 [59%] 1078 [60%] 0.52c
female [n (%)] 399 [39%] 333 [42%] 746 [41%] 732 [40%]
missing sex information [n (%)] 32 [3%] 1 [0.1%] 0
median age [range] 63 [26–86] 55 [24–91] <0.0001b 69 [33–94] 70 [34–98] 0.21b
missing age information [n (%)] 32 [3%] 1 [0.1%] 0
median BMIa [range] 27 [13–53] 26 [17-44] 0.49b 27 [17–50] 26 [16–46] <0.0001b
missing BMIa information [n (%)] 312 [30%] 294 [37%] 28 [2%] 10 [0.6%]
diabetes [n (%)] 142 [14%] 62 [8%] 0.002c 326 [18%] 247 [14%] 0.0002c
diabetes no [n (%)] 598 [58%] 434 [55%] 1456 [82%] 1558 [86%]
missing diabetes information [n (%)] 285 [28%] 291 [37%] 16 [0.9%] 5 [0.3%]
BMI, body mass index; a for case samples BMI five years before diagnosis; b Wilcoxon two sample test; c chi-square test.
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The study was approved by the Ethics Committees of the
Institute of Experimental Medicine, Academy of Sciences
of the Czech Republic, Prague (Czech Republic); Institute
for Clinical and Experimental Medicine and Faculty, Tho-
mayer Hospital, Prague (Czech Republic); Medical Faculty
of the University of Heidelberg (Germany) and the State
Medical Boards of Baden-Württemberg and Rheinland-
Pfalz (Germany). Written informed consent was obtained
from all study participants.Genotyping
Genotyping was performed using a competitive allele-
specific PCR genotyping system (KASParW; KBiosciences,
UK). PCR reactions were carried out in a 384-plate format
using 3ng DNA per reaction in a 4μl reaction volume
according to the optimal PCR protocol suggested by
KBiosciences. The genotype detection was performed
using an ABI PRISM 7900-HT Sequence Detection Sys-
tem with SDS 2.2 software (Applied Biosystems). For in-
ternal quality control, 7% of the Czech samples and 5% of
the DACHS samples were randomly selected and included
as duplicates. The concordance rate between the original
and the duplicate samples was ≥ 99%. The average call
rate was 98.2% in the Czech population and 97.1% in the
DACHS population.Statistical analysis
The observed genotype frequencies in the controls were
tested for Hardy-Weinberg equilibrium (HWE) using χ2
tests [35]. Odds ratios (ORs) and 95% confidence intervals
(CIs) for associations between genotypes and CRC risk
were estimated by logistic regression (PROC LOGISTIC,
SAS Version 9.2; SAS Institute, Cary, NC) [36]. The esti-
mated effects for all SNPs refer to the ancestral allele (A).Due to the low allele frequency shown by the majority of
the tested polymorphisms the dominant model was ap-
plied in all estimations. The ORs were adjusted for age
and sex. Additionally, a pooled analysis of the two studies
was conducted. The ORs for the pooled analysis were
adjusted for age, sex and study population.
Gene-gene interaction was studied for pair-wise inter-
action using logistic regression. To acknowledge the fact
that men are in higher risk for CRC than women and
that BMI is one of the most important risk factors for
non-syndromic CRC, an analysis stratified by sex and
BMI was performed. The threshold value for BMI was
chosen according to the median BMI in the respective
study population. To assess effect modification by sex
and BMI, multiplicative interaction terms were utilized
in multivariate regression models.
P values ≤ 0.05 were considered statistically significant.
Bonferroni correction was not applied because it would
have been overly conservative since the SNP selection was
hypothesis-driven and all selected SNPs have previously
been associated with a phenotype predisposing to CRC.
Instead, a replication study using the German sample
population was conducted to validate the initial results in
the Czech population.Signatures of selection
Next to allele frequency differences between the African
and the non-African populations, the study aimed to de-
tect additional signatures of selection in those genes that
were associated with CRC in the case–control study.
Highly variable allele frequencies in different populations
might be attributable to processes such as genetic drift,
bottleneck events or founder effects that occur during the
separation from the ancestral population. In order to en-
counter this problem, methods, which are less susceptible
to demographic influences, were applied to investigate
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itional FST value and Tajiman D test, Fay-Wu’s H and
the Standardized Integrated Haplotype Score (|iHS|)
were estimated using the Haplotter web application
that was developed on genome-wide HapMap data
(http://haplotter.uchicago.edu/) [13,15]. The Fay-Wu’s
H algorithm detects unusual excess of high frequency
derived alleles in a gene region. Strong negative Fay-
Wu’s H values are considered as signatures for a select-
ive sweep [12,15]. The iHS measures the length of hap-
lotypes around a given SNP in comparison to the
whole genome. Values < −1.5 and > 1.5 (|1.5|) give con-
clusive evidence for natural selection while values < −2
or > 2 (|2.0|) give evidence for a powerful selection sig-
nal [15,37]. Values were estimated for the YRI, the CEU
and the East Asian (ANS) population.Table 3 Genotype distribution of the polymorphisms in the C
Czech sample population
Gene SNP Allele Genotype distribution (D
Name ID. (D/A) Controls (N) C
AGT rs699 T/C 225-354-181 2
GALNT2 rs4846914 A/G 291-348-114 3
GALNT2 rs611229 T/G 314-358-101 4
IFIH1 rs1990760 T/C 282-355-109 3
SLC2A2 rs5400 C/T 586-161-14 7
SLC2A2 rs6785233 T/G 643-120-6 8
SLC2A2 rs8192675 T/C 392-313-66 4
IGFBP2 rs1470579 A/C 389-290-82 4
ENPP1 rs1044498 A/C 573-184-19 7
ENPP1 rs9493119 A/G 720-54-1 9
CYP3A[x] rs10211 A/G 668-97-4 8
CYP3A[x] rs667660 A/C 668-93-4 8
MTMR9 rs10091637 T/C 174-394-194 2
MTMR9 rs11250127 A/G 105-376-290 1
ABCA1 rs4149268 G/A 309-363-94 3
GAD2 rs2236418 A/G 529-219-22 6
GAD2 rs2839670 C/A 526-217-22 6
GAD2 rs6482538 A/G 648-120-6 8
GAD2 rs7076544 A/G 520-230-20 6
GAD2 rs8190748 A/G 400-310-55 5
ERBB3 rs11171739 T/C 341-301-121 4
KCTD10 rs7298565 G/A 158-349-248 1
CYP19A1 rs12592797 C/A 623-121-7 7
CYP19A1 rs2445761 A/G 275-352-130 3
CYP19A1 rs2446405 T/A 527-218-21 6
BBS4 rs7178130 A/G 280-366-110 3
NCP1 rs891286 C/A 145-364-203 1
A ancestral allele, D derived allele; N number; HWE Hardy Weinberg equilibrium, OR
indicate statistical significance at 5% level.Results
Candidate SNP selection
With the keywords “diabetes”, “obesity”, “metabolic syn-
drome” and “hypertension”, we found in PubMed 30
publications, which reported 246 polymorphisms to be
associated with the key-disease or with a related quanti-
tative trait. Supplementary material (Additional file 1)
provides information about all the 246 polymorphisms
with the corresponding chromosomal position, allele sta-
tus and frequency, reported associations with the dis-
eases or the traits, information about the functionality of
the SNPs and a complete reference list.
Carriers of the ancestral (A) allele of 130 SNPs had an
increased risk of a key-disease (52.8%), whereas 106 SNPs
were associated with an increased risk due to the derived (D)
allele. The majority of the SNPs were located in introns (allzech population
-DA-A) HWE Dominant modela
ases (N) Controls OR (95% CI) p value
44-492-226 0.07 1.26 (1.01-1.57) 0.04
72-450-142 0.55 1.03 (0.84-1.27) 0.76
26-427-130 0.95 0.89 (0.73-1.09) 0.25
60-455-151 0.87 1.04 (0.85-1.28) 0.72
43-217-18 0.45 1.09 (0.86-1.38) 0.49
28-146-8 0.88 0.99 (0.76-1.30) 0.95
91-409-73 0.75 1.03 (0.85-1.26) 0.75
94-376-104 0.01 1.01 (0.83-1.23) 0.91
73-200-13 0.36 0.79 (0.63-1.00) 0.05
16-69-5 0.99 1.17 (0.80-1.71) 0.42
20-150-8 0.81 1.38 (1.04-1.83) 0.03
30-144-8 0.70 1.24 (0.93-1.65) 0.14
29-496-257 0.34 0.97 (0.77-1.23) 0.79
50-431-388 0.33 0.87 (0.65-1.15) 0.32
98-458-119 0.42 1.02 (0.83-1.25) 0.87
67-276-31 0.91 0.93 (0.75-1.15) 0.51
72-277-35 0.95 0.94 (0.76-1.16) 0.57
12-164-8 0.86 1.03 (0.80-1.35) 0.80
45-304-34 0.36 1.02 (0.82-1.25) 0.88
01-395-85 0.63 0.98 (0.80-1.19) 0.81
47-354-162 0.0001
85-449-344 0.09 1.19 (0.93-1.53) 0.16
98-170-9 0.68 1.24 (0.95-1.61) 0.12
53-456-148 0.34 1.00 (0.82-1.23) 0.98
72-279-29 0.79 1.11 (0.90-1.38) 0.33
88-454-129 0.59 0.88 (0.72-1.08) 0.21
94-471-304 0.43 1.09 (0.84-1.40) 0.52
odds ratio; CI confidence interval; a adjusted for age and sex; bold numbers
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34.6%; D 47.2%). Less than 15% of all SNPs (A 17%; D 13%)
were nonsense, missense, cds-synonymous or UTR SNPs.
The frequency differences estimated for the ancestral
susceptibility alleles among the four worldwide popula-
tions were highly variable (YRI vs. any: mean 34.8; range
0.0-94.4; YRI vs. CEU: mean 20.7; range 0.0-87.3).
Twenty-nine SNPs fulfilled the selection criteria of allele
frequency difference >45% between the African and the
non-African populations and >25% between the YRI and
the CEU populations. These SNPs with their corre-
sponding genes were considered as candidates for the
CRC case–control study. After considering the location
and the function of the SNPs and the LD characteristics
of the gene regions, 28 SNPs in 15 genes were selected
for the case–control study (Table 1).
Association study
The genotype distribution of 27 of the 28 SNPs geno-
typed in the Czech control population was according to
HWE. For ERBB3 rs11171739, the genotype distributionFigure 2 Comparative data plot of the OR and 95% CI of the SNPs an
individual Czech and DACHS data adjusted for age and sex; joint data
OR odds ratio; CI confidence interval.deviated from HWE (p <0.0001) and the SNP was not
considered in the further analyses. Except for CYP3A5
rs776746, which was monomorphic in the Czech cohort,
none of the observed allele frequencies differed signifi-
cantly from the allele frequencies given in the NCBI
database (CEU population).
Three SNPs in three genes showed modest associations
with the risk of CRC in the Czech population (Table 3).
The ancestral alleles of two SNPs were associated with an
increased risk of CRC: AGT rs699 (OR 1.26; 95% CI 1.01-
1.57) and CYP3A7 rs10211 (OR 1.38; 95% CI 1.04-1.83).
In contrast, the ancestral allele of ENPP1 rs1044498 SNP
was associated with a decreased risk of CRC (OR 0.79;
95% CI 0.63-1.00). The gene-gene interaction analysis
showed no evidence of epistasis (data not shown).
A replication study in the German DACHS population
was carried out for the five SNPs with the lowest p values
(rs699, rs10211, rs1044498, rs12592797, rs7298565). None
of the analysed polymorphisms were associated with the
risk of CRC in the German population alone or in the
pooled analysis of the two populations (Figure 2).alyzed in the Czech and the DACHS cohort; dominant model,
adjusted for age and sex, stratified by study; CZ Czech cohort;
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associated with a decreased risk of CRC in the male sub-
group of the Czech population (OR 0.61; 95% CI 0.45 -
0.83; p 0.0015; pinteraction 0.01). No association was
detected in the Czech female subgroup and in the Ger-
man study (data not shown).
In the data stratified by BMI, modest associations were
detected in the Czech subgroup with a BMI >27 for
AGT rs699 (OR 1.54; CI 1.05 - 2.25; p 0.027; pinteraction
0.036) and CYP3A7 rs10211 (OR 1.78; CI 1.08 - 2.93;
p 0.023; pinteraction 0.113). No association was detected in
the German study (data not shown).
Signatures of selection
One important signature of selective pressure was
already a criterion to select the SNPs for the study: a
high allele frequency difference between HapMap popu-
lations. Thus, all SNPs that were associated with the risk
of CRC fulfilled this criterion. The highest allele fre-
quency difference among all analysed SNPs was found in
ENPP1 rs1044498 (YRI vs. HCB 94.4%; YRI vs. CEU
87.3%). The SNPs AGT rs699 and CYP3A7 rs10211
showed an allele frequency difference of 52.5% and 67%
(YRI vs. CEU), respectively.
Fay-Wu’s H and |iHS| were analysed as further signa-
tures of selection. All estimates of Fay-Wu’s H and |iHS|
refer to SNPs that are linked to the genotyped SNPs
(r2=1.0), because direct values were not available in the
Haplotter web application http://haplotter.uchicago.edu/
[13,15]. Signatures of a selective sweep indicated by Fay-
Wu’s H were found for CYP3A7 rs2687075 (r2 to
rs10211=1.0), with strong negative H estimates in the
ANS population (−28.8) and in the CEU population
(−49.6). The other two analysed polymorphisms did not
show strong negative H values (> −8.0) or even showed
positive values (Figure 3a). Values of |iHS| >1.5 that give
conclusive evidence for natural selection in the CEUFigure 3 Plot of Fay-Wu’s H (a) and plot of the Standardized Integrate
associated with CRC in the Czech population. Comparison of the African (Y
to SNPs that are linked to the genotyped SNPs because direct values were
conclusive evidence for natural selection [12,15,37].population were found for SNPs in AGT (rs2148582,
r2 = 1.0 to rs699; |iHS| = 1.62), ENPP1 (rs6926970, r2 =
1.0 to rs1044498; |iHS| = 1.58) and CYP3A7 (rs2687075,
r2 = 1.0 to rs10211; |iHS| = 1.67) (Figure 3b).
Discussion
The present study intended to crosslink susceptibility var-
iants of nutrition-related complex diseases to CRC. In fact,
the results in the Czech hospital-based case–control study
suggested that polymorphisms in AGT, CYP3A7 and
ENPP1 may be associated with the risk of CRC. However,
replication in the population-based German DACHS
population did not confirm the associations.
From the 246 SNPs that have been reported to be
associated with a nutrition-related disease, 130 showed
ancestral susceptibility to overall risk of obesity, T2D,
metabolic syndrome or hypertension. However, only 29
SNPs fulfilled the initial selection criterion of ≥45% allele
frequency difference between the YRI and any HapMap
population, indicating selective pressure. Except ABCA1
that has been found to be mutated in CRC tumour sam-
ples [38,39], none of the 15 genes of the present study
has previously been associated with the risk of CRC
(http://www.ncbi.nlm.nih.gov/; http://www.hugenavigator.
net/ CancerGEMKB/home.do) [40].
The association study in the Czech population indi-
cated ancestral susceptibility to the risk of CRC for the
missense AGT SNP rs699 and to the 3’UTR SNP
rs10211 in CYP3A7. Interestingly, SNPs in these two
genes feature similar phenotypic effects, such as predis-
posing to hypertension and salt sensitivity [18].
Published data about AGT suggests that the ancestral
allele of the probable pathogenic SNP rs699 (M268T), as
well as the ancestral alleles of the missense SNP rs4762
(T207M) and the 50UTR SNP rs5051, predispose to es-
sential hypertension, increased plasma angiotensinogen
and increased frequency of preeclampsia (OMIM ID:d Haplotype Score (|iHS|) (b). Estimates for the SNPs that were
RI), European (CEU) and East Asian (ANS) population. All estimates refer
not available for the genotyped SNPs. * indicate values that provide
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rs699) has been demonstrated to affect the transcription
rate of AGT [41,42]. AGT (angiotensinogen [serpin pep-
tidase inhibitor, clade A, member 8]) is an important
member of the renin-angiotensin system that regulates
blood pressure and fluid homeostasis probably through
influencing sodium sensitivity [41,42].
Also the intronic CYP3A5 SNP rs776746 has previ-
ously been associated with hypertension and salt sensi-
tivity [9,18]. This SNP has been reported to result in an
incorrectly spliced mRNA and in a truncated non-
functional protein. In the Czech population, rs776746
was monomorphic. However, the CYP3A7 SNP rs10211
- also located within the same cytochrome P450 gene
cluster and linked to rs776746 in the HapMap CEU
population (r2=0.82) - showed nominally significant as-
sociation with the risk of CRC. The genes of the cyto-
chrome P450 gene family encode for some of the most
important enzymes involved in the metabolism of vari-
ous xenobiotics and endogenous substrates such as
cholesterol, steroids, environmental carcinogens and
drugs [43]. In particular, CYP3 enzymes are responsible
for the metabolism of eicosanoids.
The allele frequencies of the genotyped SNPs rs699
and rs10211 and the two functional SNPs rs5051 and
rs776746 are highly variable among worldwide popula-
tions, with higher frequencies of the derived alleles in
non-African populations while the ancestral alleles pre-
dominate in the African population. The values of |iHS|
determined for SNPs that are fully linked to rs699 and
rs10211 provided conclusive evidence for natural selec-
tion in the population with European ancestry. Addition-
ally, rs2687075 (r2=1.0 to rs10211) in CYP3A7 showed
strong negative values of Fay-Wu’s H that were consid-
ered as signatures for a selective sweep in non-African
populations [12,15]. Previous studies have already sug-
gested AGT and CYP3A5 as targets of selection, and
have additionally connected the two genes directly by
their related function [18,42]. In AGT, selection was par-
ticularly suggested to work on the promoter that con-
tains rs699 and on SNPs in high LD with it. This
selection was attributed to altered requirements for the
human to maintain sodium homeostasis [42]. Since the
derived allele, that predisposes to salt tolerance, is not
yet fixed in non-African populations, the remaining an-
cestral allele, that predisposes to salt sensitivity, shows
ancestral susceptibility to related diseases such as hyper-
tension, preeclampsia [41,42] and CRC.
A possible association with the risk of CRC and signa-
tures of recent selection were also observed for one
polymorphism in ENPP1. However, in contrast to the
initial hypothesis, the ancestral allele of rs1044498 was
associated with a decreased risk of CRC in the Czech
population. ENPP1 is a member of the ecto-nucleotidepyrophosphatase/phosphodiesterase (ENPP) family. The
encoded protein interacts with the insulin receptor
thereby inhibiting subsequent signalling. In previous
studies, the ancestral allele of the missense polymorph-
ism rs1044498 (Q121K) has been associated with more
vivid insulin receptor binding, stronger inhibition of in-
sulin signalling, insulin resistance, an increased risk of
T2D and an increased risk of myocardial infarction
(OMIM ID: 608446) [9,44,45]. The associations were
most pronounced in cohorts that underwent lifestyle
interventions to improve an individual’s weight or chol-
esterol level [45]. It is possible that the effect of ENPP1
on the risk of metabolic syndrome and the risk of CRC
is highly dependent on additional environmental factors
or modifiers.
Unfortunately, we were not able to validate our results
in the independent German case–control study. Since
the Czech and the German populations should not differ
significantly in their genetic constitution, differences in
nutrition or other environmental factors may contribute
to the observed results or the associations may be a
chance finding [46,47]. Since the selection of candidate
SNPs was based on complex gene-environmental inter-
actions - with the SNP contributing to a phenotype that
predisposes to CRC - the detected associations are
expected to be weaker than the associations for the ori-
ginal intermediate phenotype. Already in the original
reports about the associations of SNPs with nutrition-
related diseases, low ORs were detected in most of the
cases. As we studied only a few polymorphisms per gene,
other polymorphisms with low LD (r2<0.8) or rare SNPs
(MAF<0.05) that may contribute to the risk of CRC
might have been missed. However, considering previ-
ously reported associations of several SNPs in the three
described genes with components of the metabolic syn-
drome, the ancestral nature of the risk alleles, and the
detected signatures of selection, a true nature of the
modest effects on CRC risk in the Czech population
cannot be excluded [48]. Especially the close resem-
blance of the detected associations and function of SNPs
in AGT and CYP3A7 may indicate a true effect of the
polymorphisms on CRC susceptibility.
Conclusion
Our study showed evidence of association of the ancestral
alleles of polymorphisms in AGT and CYP3A7 and the
derived allele of a polymorphism in ENPP1 with an
increased risk of CRC in Czechs, but not in Germans. The
ancestral alleles of these SNPs have previously been asso-
ciated with the nutrition-related diseases hypertension
(AGT and CYP3A7) and insulin resistance (ENPP1). Fu-
ture studies may shed light on the complex genetic and
environmental interactions between different types of
nutrition-related diseases. The application of additional
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tures of selection, or pathway membership, might help to
narrow down the numerous published polymorphisms
and to find the most promising candidates for association
studies. Large study populations that provide the possibil-
ity to define large subgroups with specific pre-diagnostic
features may be used to review the actual function of such
polymorphisms and may provide further insights into the
evolution of common complex diseases.
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